Neste Jacobs and National Bioproducts Institute sign a biopharma agreement
Neste Jacobs Oy
Press release
9 January 2013 at 9.00 am
Neste Jacobs and National Bioproducts Institute sign a biopharma agreement
Technology, engineering and project management company Neste Jacobs Oy and the
South African plasma fractionation company National Bioproducts Institute have
signed a service agreement covering production consulting, engineering and
executing of services related to plasma fractionation processes.
Under the agreement Neste Jacobs will carry out engineering, procurement,
construction/installation, qualification, and validation services for National
Bioproducts Institute in South Africa. Neste Jacobs' expertise in plasma
fractionation unit operations, operational aspects and knowledge of particular
features of plasma fractionation processes has made the company a leading
partner in the field. The agreement between the two companies aligns with Neste
Jacobs' strategy to assist governments and other health care providers worldwide
to become self-sufficient in the manufacture of blood plasma products.
"We are very happy to co-operate with National Bioproducts Institute. Blood
plasma fractionation is a substantial and growing part of our business and,
together with our other core competences, ensures our growth globally," says
Neste Jacobs' Managing Director Jarmo Suominen.
"We have been very satisfied with Neste Jacobs' delivery and performance and
based on this experience they were a natural choice for us," says David
Stubbings, the CEO of National Bioproducts Institute. "We wanted a strong
partner with solid experience in the plasma products industry and in this
respect Neste Jacobs was our first choice."
Neste Jacobs Oy
Jarmo Suominen
Managing Director
For more information, please contact:
Jarmo Suominen, Managing Director, Neste Jacobs Oy, tel. +358 50 458 3399
David Stubbings, CEO, National Bioproducts Institute, tel. + 27 3-1714 6700
Neste Jacobs in brief
Neste Jacobs is a preferred solution provider of high-quality technology,
engineering, and project services for a wide range of industries in the
chemicals and biotechnology fields. We have more than 50 years of experience in
technology development and industrial investment projects in Europe, North
America, Asia and the Middle East, and are looking to grow in the expanding
markets in particular. Neste Jacobs' specific plasma fractionation experience
dates back to the late 1970's, since when we have provided successful plasma
fractionation solutions for our customers. We employ some 1,000 professionals
globally. www.nestejacobs.com
National Bioproducts Institute in brief
National Bioproducts Institute is a not-for-profit company, whose core business
is the manufacture of pharmaceutical products from human plasma, using a process
of protein fractionation. As a registered pharmaceutical manufacturer, NBI is
committed to the manufacture of safe, effective and high quality plasma-derived
pharmaceutical products that provide life-saving therapy and improve the quality
of life of patients with rare and serious diseases in South and Sub-Saharan
Africa. www.nbi-kzn.org.za
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Neste Oil Oyj via Thomson Reuters ONE
[HUG#1669178]
